Cargando…
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
Platelets are the main effectors of primary hemostasis but also cause thrombosis in pathological conditions. Antiplatelet drugs are the cornerstone for the prevention of adverse cardiovascular events. Monitoring the extent of platelet inhibition is essential. Currently available platelet function te...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790905/ https://www.ncbi.nlm.nih.gov/pubmed/36578552 http://dx.doi.org/10.3389/fphar.2022.1078722 |